Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies

References

• Abdelbary G. (2011). Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Dev Technol 16:44–56.
   PubMed Web of Science ®Google Scholar
• Aburahma MH, Abdelbary GA. (2012). Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Int J Pharm 422:139–50.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, et al. (2009). Chemical penetration enhancers: a patent review. Expert Opin Ther Pat 19:969–88.
   PubMed Web of Science ®Google Scholar
• Al-Mahallawi AM, Abdelbary AA, Aburahma MH. (2015). Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. Int J Pharm 485:329–40.
   PubMed Web of Science ®Google Scholar
• Alvarez-Figueroa M, Araya-Silva I, Díaz-Tobar C. (2006). Iontophoretic transdermal delivery of haloperidol. Pharm Dev Technol 11:371–5.
   PubMed Web of Science ®Google Scholar
• Azarbayjani AF, Tan EH, Chan YW, Chan SY. (2009). Transdermal delivery of haloperidol by proniosomal formulations with non-ionic surfactants. Biol Pharm Bull 32:1453–8.
   PubMed Web of Science ®Google Scholar
• Cevc G. (1996). Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 13:257–388.
   PubMed Web of Science ®Google Scholar
• Cevc G. (2003). Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet 42:461–74.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. (2001). New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochim Biophys Acta 1514:191–205.
   PubMed Web of Science ®Google Scholar
• Derendorf H. 1995. Drug actions: basic principles and therapeutic aspects. USA: CRC Press, 116–125.
   Google Scholar
• Dold M, Samara MT, Li C, et al. (2015). Haloperidol versus first‐generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Cochrane Database Syst Rev 1:CD009831.
   PubMed Web of Science ®Google Scholar
• El-Hadidy GN, Ibrahim HK, Mohamed MI, El-Milligi MF. (2012). Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm 38:64–72.
   PubMed Web of Science ®Google Scholar
• El-Setouhy DA, Ibrahim A, Amin MM, et al. (2016). Intranasal haloperidol-loaded miniemulsions for brain targeting: evaluation of locomotor suppression and in-vivo biodistribution. Eur J Pharm Sci 92:244–54.
   PubMed Web of Science ®Google Scholar
• Elgorashi AS, Heard CM, Niazy EM, et al. (2008). Transdermal delivery enhancement of haloperidol from gel formulations by 1, 8‐cineole. J Pharm Pharmacol 60:689–92.
   PubMed Web of Science ®Google Scholar
• Ellaithy H, El-Shaboury KM. (2002). The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS PharmSciTech 3:77–85.
   Google Scholar
• Essa B, Sakr T, Khedr MA, et al. (2015). 99m Tc-amitrole as a novel selective imaging probe for solid tumor: in silico and preclinical pharmacological study. Eur J Pharm Sci 76:102–9.
   PubMed Web of Science ®Google Scholar
• Gad HA, El-Nabarawi MA, El-Hady SSA. (2008). Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis. AAPS PharmSciTech 9:878.
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhao F, Li N, et al. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 244:73–80.
   PubMed Web of Science ®Google Scholar
• Ibrahim A, Sakr T, Khoweysa O, et al. (2014). Formulation and preclinical evaluation of 99mTc–gemcitabine as a novel radiopharmaceutical for solid tumor imaging. J Radioanal Nucl Chem 302:179–86.
   Web of Science ®Google Scholar
• Ibrahim A, Sakr T, Khoweysa O, et al. (2015). Radioiodinated anastrozole and epirubicin as potential targeting radiopharmaceuticals for solid tumor imaging. J Radioanal Nucl Chem 303:967–75.
   Web of Science ®Google Scholar
• Kakkar S, Kaur IP. (2011). Spanlastics—A novel nanovesicular carrier system for ocular delivery. Int J Pharm 413:202–10.
   PubMed Web of Science ®Google Scholar
• Kakkar S, Pal Kaur I. (2013). A novel nanovesicular carrier system to deliver drug topically. Pharm Dev Technol 18:673–85.
   PubMed Web of Science ®Google Scholar
• Kang L, Liu X, Sawant P, et al. (2005). SMGA gels for the skin permeation of haloperidol. J Control Release 106:88–98.
   PubMed Web of Science ®Google Scholar
• Kornhuber J, Schultz A, Wiltfang J, et al. (1999). Persistence of haloperidol in human brain tissue. Am J Psychiatry 156:885–90.
   PubMed Web of Science ®Google Scholar
• Kota J, Machavaram KK, Mclennan DN, et al. (2007). Lymphatic absorption of subcutaneously administered proteins: influence of different injection sites on the absorption of darbepoetin alfa using a sheep model. Drug Metab Dispos 35:2211–17.
   PubMed Web of Science ®Google Scholar
• Kumar A, Pathak K, Bali V. (2012). Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents. Drug Discov Today 17:1233–41.
   PubMed Web of Science ®Google Scholar
• Kumar R, Singh B, Bakshi G, Katare OP. (2007). Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation. Pharm Dev Technol 12:591–601.
   PubMed Web of Science ®Google Scholar
• Lim PFC, Liu XY, Kang L, et al. (2006). Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Int J Pharm 311:157–64.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. (2005). Preparation and characterisation of liposomes encapsulating ketoprofen–cyclodextrin complexes for transdermal drug delivery. Int J Pharm 298:55–67.
   PubMed Web of Science ®Google Scholar
• Manconi M, Sinico C, Caddeo C, et al. (2011). Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm 412:37–46.
   PubMed Web of Science ®Google Scholar
• Moore JW, Flanner HH. (1996). Mathematical comparison of dissolution profiles. Pharm Technol 20:64–74.
   Google Scholar
• Motaleb M, El-Kolaly M, Ibrahim A, El-Bary AA. (2011). Study on the preparation and biological evaluation of 99mTc–gatifloxacin and 99mTc–cefepime complexes. J Radioanal Nucl Chem 289:57–65.
   Web of Science ®Google Scholar
• Mura S, Manconi M, Sinico C, et al. (2009). Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm 380:72–9.
   PubMed Web of Science ®Google Scholar
• Nour SA, Abdelmalak NS, Naguib MJ, et al. (2016). Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies. Drug Deliv 23:3681–95.
   PubMed Web of Science ®Google Scholar
• Potts RO, Guy RH. (1992). Predicting skin permeability. Pharm Res 9:663–9.
   PubMed Web of Science ®Google Scholar
• Radwan SaA, Elmeshad AN, Shoukri RA. (2017). Microemulsion loaded hydrogel as a promising vehicle for dermal delivery of the antifungal sertaconazole: design, optimization and ex vivo evaluation. Drug Dev Ind Pharm 43:1351–65.
   PubMed Web of Science ®Google Scholar
• Saher O, Ghorab DM, Mursi NM. (2016). Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis. Pharm Dev Technol 21:600–10.
   PubMed Web of Science ®Google Scholar
• Sakr T, El-Safoury D, et al. (2013a). Biodistribution of 99mTc‐sunitinib as a potential radiotracer for tumor hypoxia imaging. J Labelled Comp Radiopharm 56:392–5.
   PubMed Web of Science ®Google Scholar
• Sakr T, Moustapha M, Motaleb M. (2013b). 99mTc-nebivolol as a novel heart imaging radiopharmaceutical for myocardial infarction assessment. J Radioanal Nucl Chem 295:1511–16.
   Web of Science ®Google Scholar
• Schmid-Wendtner M-H, Korting HC. (2006). The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 19:296–302.
   PubMed Web of Science ®Google Scholar
• Scognamiglio I, De Stefano D, Campani V, et al. (2013). Nanocarriers for topical administration of resveratrol: a comparative study. Int J Pharm 440:179–87.
   PubMed Web of Science ®Google Scholar
• Shamma RN, Elsayed I. (2013). Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization. J Liposome Res 23:244–54.
   PubMed Web of Science ®Google Scholar
• Sinha V, Kaur MP. (2000). Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26:1131–40.
   PubMed Web of Science ®Google Scholar
• Tanner T, Marks R. (2008). Delivering drugs by the transdermal route: review and comment. Skin Res Technol 14:249–60.
   PubMed Web of Science ®Google Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. (2015). Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments. Int J Pharm 483:77–88.
   PubMed Web of Science ®Google Scholar
• Tenjarla S, Puranajoti P, Kasina R, Mandal T. (1998). Preparation, characterization, and evaluation of miconazole–cyclodextrin complexes for improved oral and topical delivery. J Pharm Sci 87:425–9.
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Debernardi F, Gallarate M. (2002). Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 241:319–27.
   PubMed Web of Science ®Google Scholar
• Vaddi H, Ho P, Chan S. (2002). Terpenes in propylene glycol as skin‐penetration enhancers: Permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci 91:1639–51.
   PubMed Web of Science ®Google Scholar
• Vaddi H, Wang L, Ho P, Chan S. (2001). Effect of some enhancers on the permeation of haloperidol through rat skin in vitro. Int J Pharm 212:247–55.
   PubMed Web of Science ®Google Scholar
• Volavka J, Cooper T, Czobor P, et al. (1992). Haloperidol blood levels and clinical effects. Arch Gen Psychiatry 49:354–61.
   PubMed Web of Science ®Google Scholar